Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEAM vs MRNA✓SelectedUSD · MRNATEAM vs MRNA performance historyLatest closeAs of+1.23%11/20
Stock and ETF performance explorer

TEAM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+67.4%
MRNA return
+786.4%
Excess return
-719.0%
Maximum drawdown
-87.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.2%-2.2%+3.4%+1.4%
7D-10.2%-12.7%+2.5%-9.1%
30D-40.3%-20.7%-19.6%-39.3%
3M-23.0%+46.3%-69.3%-26.5%
6M+56.2%+305.2%-249.1%+23.1%
YTD-17.0%+561.2%-578.2%-40.0%
1Y-6.5%+772.1%-778.6%-35.3%
3Y-27.6%+147.0%-174.6%-42.9%
5Y-68.7%-26.1%-42.6%-72.4%
All+67.4%+786.4%-719.0%+24.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling